Legal Opinion of Guohao Law Firm (Hangzhou) on the granting of the 2023 Restricted Stock Incentive Plan of Jiangsu Nuotai Aosano Biopharmaceutical Co., Ltd.

SZSI · Jun 28, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.